Marcusson, Eric G.
Providence Therapeutics Holdings Inc., Calgary, AB, Canada. · Marcusson Consulting, San Francisco, CA, USA.
3 papers on CoChatORCID 0000-0002-0504-8674
Most cited papers
- Verified
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell
MicroRNA in disease regulationExtracellular vesicles in disease
Cited by 1,476
- Verified
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., et al. (2022) · Science Advances
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 56
- Verified
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
Abe, K. T., Hu, Q., Mozafarihashjin, M., Samson, R., Manguiat, K., Robinson, A., Rathod, B., Hardy, W. R., Wang, J. H., Iskilova, M., et al. (2021) · medRxiv
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free